🚀 Pharmidex In Silico Drug Discovery – Step 4: Molecular Docking! 🔬💻
February 26, 2025

Pharmidex continues advancing computational drug discovery! After identifying active/binding sites, our Molecular Docking step ensures precise interaction analysis between potential drug candidates and target proteins, streamlining lead optimization.


✨ Why is this step key?

✅ Predicts binding affinity and stability of drug candidates

✅ AI-enhanced docking for high-precision molecular interactions

✅ Accelerates hit-to-lead identification with accurate simulations

✅ Seamlessly integrates with the next in silico pipeline steps


By combining cutting-edge modeling and expert-driven analysis, we de-risk drug development and fast-track novel therapeutic discoveries.


📽️ Watch our latest video (3/5) showcasing how we refine drug-target interactions through Molecular Docking!


📩 Let’s collaborate to transform drug discovery!


#DrugDiscovery #Pharmidex #AIinBiotech #MolecularDocking #PharmaceuticalInnovation

LC-MS bioanalysis At Pharmidex

February 4, 2026
At Pharmidex , we deliver high-quality LC-MS bioanalysis to support drug development across a wide range of analysis. Our experienced team supports preclinical, translational and clinical studies, providing accurate, reliable data under GLP and GCP to help drive confident decision-making. Learn more about our LC-MS capabilities: https://www.pharmidex.com/Discovery-Bioanalysis

🔬 Clinical Chemistry Services at Pharmidex

February 2, 2026
Pharmidex offers high-quality Clinical Chemistry services delivering accurate, reliable data to support drug development. Our expert team and robust, quality-driven workflows enable trusted results that help accelerate decision-making and strengthen collaboration with pharma companies, CROs and academic partners. By working together, we support better science and more efficient drug development. 👉 Learn more: https://www.pharmidex.com/Clinical-chemistry

BIA Annual Gala Dinner

January 29, 2026
Pharmidex is delighted to share that Ash Alavijeh , Head of Operations, will be attending the UK BioIndustry Association (BIA) Annual Gala Dinner at the Roundhouse, London. Ash is looking forward to connecting with pharma and biotech colleagues to explore new collaborations, partnerships, and opportunities, all with the shared goal of advancing drug discovery and development. If you’re attending, feel free to connect with Ash this evening.
More Posts